Plazomicin is effective in a non-human primate pneumonic plague model

Clicks: 367
ID: 116966
2016
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #11 of 183 articles by views in bioorganic & medicinal chemistry

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 183 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The efficacy of plazomicin for pneumonic plague was evaluated in a non-human primate model. African Green monkeys challenged with a lethal aerosol of Yersinia pestis [median (range) of 98 (15-331) LD50s] received placebo (n=12) or 'humanized' dose regimens (6.25, 12.5 or 25mg/kg every 24h …
Reference Key
wm2016bioorganicplazomicin Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mega WM;Doyle-Eisele M;Cass RT;Kostrub CF;Sherwood RL;Metz MA;Cirz RT;;
Journal bioorganic & medicinal chemistry
Year 2016
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/27614915
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE animals pubmed abstract nih national institutes of health national library of medicine Disease Models animal* dose-response relationship drug chlorocebus aethiops molecular conformation plague / drug therapy* pmid:27614915 doi:10.1016/j.bmc.2016.08.049 william m mega melanie doyle-eisele ryan t cirz sisomicin / analogs & derivatives* sisomicin / chemistry sisomicin / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.